Title : Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension.

Pub. Date : 2017 Nov

PMID : 28387058






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the EMPA-REG BP trial, empagliflozin significantly reduced systolic and diastolic blood pressure (SBP and DBP) compared with placebo at week 12 in patients with type 2 diabetes mellitus (T2DM) and hypertension. empagliflozin D-box binding PAR bZIP transcription factor Homo sapiens